A dual Keap1 and p47phox inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis.
Cell Death Dis
; 13(9): 824, 2022 09 26.
Article
in En
| MEDLINE
| ID: mdl-36163178
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Diabetes Mellitus
/
Atherosclerosis
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Cell Death Dis
Year:
2022
Document type:
Article
Affiliation country:
China